Saral Diagnostics Classic Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 21-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 21-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
as on 21-12-2024
- Revenue -24.74%
(FY 2023)
- Profit -229.31%
(FY 2023)
- Ebitda -90.89%
(FY 2023)
- Net Worth -9.37%
(FY 2023)
- Total Assets -13.87%
(FY 2023)
About Saral Diagnostics Classic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹10.00 Cr.
Kamal Trehan, Ravi Gupta, Vijay Giridher, and Four other members serve as directors at the Company.
- CIN/LLPIN
U93000DL2017PTC317430
- Company No.
317430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Saral Diagnostics Classic?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mudit Gupta  | Director | 17-Aug-2023 | Current |
| Kamal Trehan | Director | 15-May-2017 | Current |
| Ravi Gupta | Director | 15-Oct-2022 | Current |
| Vijay Giridher | Director | 15-May-2017 | Current |
| Akshay Bhasin | Director | 15-May-2017 | Current |
| Neena Bhasin | Director | 15-May-2017 | Current |
Financial Performance of Saral Diagnostics Classic.
Saral Diagnostics Classic Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.74% decrease. The company also saw a substantial fall in profitability, with a 229.31% decrease in profit. The company's net worth dipped by a decrease of 9.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saral Diagnostics Classic?
Unlock access to Saral Diagnostics Classic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Saral Advanced Diagnostic Private LimitedActive 26 years 3 monthsKamal Trehan, Ravi Gupta and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Aug 2017 | ₹10.00 Cr | Open |
How Many Employees Work at Saral Diagnostics Classic?
Saral Diagnostics Classic has a workforce of 14 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saral Diagnostics Classic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saral Diagnostics Classic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
